Today's letter from the Editor
£45000 - £55000 per annum + 30 days holiday: Ashdown Group: Finance Manager - ...
£28000 - £30000 per annum: Ashdown Group: 3rd Line Support Engineer / Network ...
£26000 - £33000 per annum: Recruitment Genius: A Web Developer is required to ...
£45000 per annum: Ashdown Group: PeopleSoft Application Support & Development ...
The Business Matrix: Tuesday 27 August 2013
Tradesmen ‘work the longest hours’
Britain’s tradesmen work longer than bankers, as holidays are sacrificed and weekends ignored in a bid to squeeze more jobs in. The average tradesman works between 41 and 50 hours a week, more than bankers, who are at their desk for an average of 40.9 hours; doctors, on 38.4 hours; barristers and judges, 36 hours; and accountants, 35.6 hours, a survey by Screwfix has found.
Telefonica’s bid gets Slim chance
Telefonica, the Spanish mobile giant that owns O2, yesterday raised its bid for Germany’s E-Plus and won the backing of billionaire Carlos Slim, who could have blocked the deal.
Telefonica offered to pay Holland’s KPN €8.55bn (£7.34bn) for E-Plus an increase on the €8.1bn it had offered in July. Mr Slim’s America Movil, the largest single shareholder in KPN with a 30 per cent stake, said it would vote in favour.
China sees signs of stabler growth
China’s government yesterday tried to reassure companies and its public about its economy’s health, saying growth is stabilising after a lengthy decline, and should hit the official target of 7.5 percent for the year. “There are growing signs of stabilisation and also of further growth,” said a spokesman, Sheng Laiyun, at a news briefing. “We are confident we can hit our full-year growth target.”
Cancer drugs boost for Astra
UK drugs giant AstraZeneca took a further step to bolster its pipeline of new cancer drugs yesterday by agreeing to acquire privately held US biotech company Amplimmune for up to $500m (£321m). Amplimmune specialises in developing treatments designed to help the immune system fight cancer. The purchase will give AstraZeneca access to a number of compounds in pre-clinical development.
- 1 End of the licence fee: BBC to back radical overhaul of how it is funded
- 2 This restaurant has misunderstood the concept of 'cheese and biscuits'
- 3 Raif Badawi, the Saudi Arabian blogger sentenced to 1,000 lashes, may now face death penalty
- 4 Delhi bus rapist blames dead victim for attack because 'girls are responsible for rape'
- 5 PornHub turns masturbation into energy in bid to save the planet